News Wire ~ 3rd Party Press Release
FDA Warns About Serious Health Problems with High Doses of Benadryl
Teen misuse sparked by dangerous “Benadryl Challenge” promoted on social media.
Research Links the Hormones You’re Born with to Lifetime Risk for Immunological Diseases
Study answers questions about why females are at increased risk for common diseases that involve or target the immune system like asthma, allergies, migraines and irritable bowel syndrome.
AAAAI and NASN Release Guidance on Managing Food Allergies in Schools During COVID-19
New document addresses specific food processes, anaphylaxis treatment, and additional safety considerations for schools during COVID-19 to keep students with food allergies safe.
FARE Announces Living Teal™ Global Summit Speaker Lineup
Diverse roster of speakers and influencers to cover wide range of topics, reach new audiences, expand awareness of food allergies.
Study Finds Fall Babies at Higher Risk of Lifetime of Allergic Diseases
Children born in the fall were much more likely to experience all of the conditions associated with the atopic march.
FARE Announces 2020 Contains: Courage® Research Retreat
Virtual two-day event to feature guest appearance by Dr. Anthony Fauci and sessions open to public for the first time ever.
Nestlé to Acquire Aimmune Therapeutics
Nestlé Health Science and Aimmune to create a global leader in food allergy prevention and treatment.
Is 120 Years of Breeding Wheat Responsible for the Rise in Celiac Disease, Gluten...
The wheat itself may not be the problem.
Aquestive’s Sublingual Epinephrine Film Receives FDA Fast Track Designation for Treatment of Anaphylaxis
First planned PK clinical trial expected to begin during the third quarter of 2020.
Kaleo Announces Public and Private Insurance Plans to Cover Allerject, the Canadian Version of...
Ontario and Quebec public drug plans are first to list ALLERJECT with other provinces expected to follow soon.
